A Randomized Clinical Trial of Cognitive Behavior Therapy (CBT) and Pharmacotherapy for Major Depressive Disorder

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

TCTR

Registry ID

TCTR20200903003

Enrollment

Unknown

Registered

2020-09-03

Start date

2020-10-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

There was no harm for subjects. Cognitive Behavior Therapy, Pharmachotherapy, Major Depressive Disorder

Interventions

Both interventions would be given,CBT based Interventions,Pharmachotherapy (Prescribed by Consultant Psychiatrist)

Experimental Behavioral,Experimental Behavioral,Experimental Drug

Cognitive Behavior Therapy and Pharmacotherapy ,Cognitive Behavior Therapy,Pharmacotherapy

Eligibility

Sex/Gender

All

Age

25 Years to 45 Years

Inclusion criteria

Inclusion criteria: Diagnosed patienst with major depressive disorders With mild to moderate severity With single episode Duration of illness less then 6 months With read, write and understand ability

Exclusion criteria

Exclusion criteria: Patients other than MDD were excluded Patients with comorbid illness were excluded With multiples episodes More than 6 months duration of illness MDD with severe rage

Design outcomes

Primary

Measure	Time frame
Therapeutic outcomes After 3/4 months Depression, Anxiety, Stress Scale, Cognitive Distortion Scale, Subjective Well-being Scale	—

Secondary

Measure	Time frame
Therapeutic alliance and transference after 3/4 months Therapeutic Alliance Scale and Transference Scale	—

Countries

Pakistan

Contacts

Public ContactQasir Abbas

Government College University Faisalabad

qasirabbas47@yahoo.com3337683133

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026